Oldest

levodopa

Image shows a melanoma skin cancer growth.

·July 5, 2017·4 min read

Increased Risk For Melanoma in Parkinson’s Patients

A new study reveals people with Parkinson's disease face a higher risk of developing melanoma skin cancer, and vice versa, than those without the diseases. Parkinson's patients were 4 times more likely to develop skin cancer than those without the movement impairing disease. Additionally, people diagnosed with melanoma were at a fourfold risk of developing Parkinson's.

$Image shows a brain.$

Featured Neurology Open Neuroscience Articles

·January 8, 2018·3 min read

Parkinson’s ‘Jerking’ Side Effects Detected by Algorithm

Researchers have developed a new mathematical algorithm that can detect dyskinesia in Parkinson's patients.

Featured Neurology Psychology

·June 20, 2018·3 min read

Half of Those on Parkinson’s Drugs Develop Impulse Control Problems

A new study reports Parkinson's patients who take dopamine agonists are more likely to develop impulse control disorders.

Featured Neurology Neuroscience

·July 8, 2018·3 min read

Discovering Dopamine’s Role in the Brain

Researchers pay tribute to Arvid Carlsson, who was awarded the Nobel Prize for his research into dopamine, and evaluate what his research means to modern neuroscience.

Featured Neurology Open Neuroscience Articles

·January 18, 2019·4 min read

How Gut Bacteria Affects the Treatment of Parkinson’s Disease

A new study reveals how bacteria in the gut is able to metabolize levodopa into dopamine in Parkinson's patients.

Featured Neuroscience

·January 24, 2019·5 min read

Dopamine Modulates Reward Experiences Elicited by Music

Researchers report a causal link between dopamine, musical pleasure and motivation. Phamacologically manipulating dopamine levels, researchers found increasing dopamine increased the hedonic experience and motivational response to listening to a piece of music.

Featured Neurology Neuroscience Open Neuroscience Articles

·June 13, 2019·6 min read

Gut Bacteria Interferes with Metabolism of Parkinson’s Drug

Study provides first concrete examples of how the microbiome can interfere with a drug's intended path throughout the body.

This shows a person holding a cup of wateri

Featured Genetics Neurology Neuroscience

·May 1, 2020·5 min read

Parkinson’s dyskinesia mechanism explained

Involuntary movements and tremors caused as a result of taking dopamine replacement medications for Parkinson's disease can be alleviated through the suppression of RasGRP1.

Featured Neurology Neuroscience

·May 24, 2021·3 min read

Step-Closer to Nasal Spray Drug Delivery for Parkinson’s Disease

A new gel that contains levodopa can adhere to nasal tissue. The gel releases levodopa directly into the blood and brain. Researchers say the preliminary data reveals the gel has proven to be effective in animal models.

Featured Neuroscience Psychology

·January 27, 2023·4 min read

A Drug That Increases Dopamine Can Reverse the Effects of Inflammation on the Brain in Depression

Levodopa, a drug commonly prescribed for the treatment of Parkinson's disease that increases dopamine in the brain was found to reverse the effects of neuroinflammation on the reward system and improve symptoms associated with depression.

levodopa

Increased Risk For Melanoma in Parkinson’s Patients

Parkinson’s ‘Jerking’ Side Effects Detected by Algorithm

Half of Those on Parkinson’s Drugs Develop Impulse Control Problems

Discovering Dopamine’s Role in the Brain

How Gut Bacteria Affects the Treatment of Parkinson’s Disease

Dopamine Modulates Reward Experiences Elicited by Music

Gut Bacteria Interferes with Metabolism of Parkinson’s Drug

Parkinson’s dyskinesia mechanism explained

Step-Closer to Nasal Spray Drug Delivery for Parkinson’s Disease

A Drug That Increases Dopamine Can Reverse the Effects of Inflammation on the Brain in Depression

Shaping Young Minds: Neurodevelopment Interventions for Psychiatric Disorders

Ultra-Processed Foods: AI’s New Contribution to Nutrition Science

Aging Myelin: A New Perspective in Alzheimer’s Disease Progression

Promising Phase 2 Trial Results for Pembrolizumab in Metastatic Brain Cancer

Subscribe